Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 4:17 AM
Ignite Modification Date: 2025-12-26 @ 3:18 AM
NCT ID: NCT00854620
Description: None
Frequency Threshold: 0
Time Frame: None
Study: NCT00854620
Study Brief: Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Sorafenib * Cycle 1: 400 mg BID sorafenib * Cycle 2: 600 mg BID sorafenib * Cycle 3+: 800 mg BID sorafenib Sorafenib: Sorafenib administered in escalating 28-days cycles (400, 600 and 800 mg BID) None None 0 9 9 9 View
Serious Events(If Any):
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
General disorders and administration site conditions-other, Hand foot Syndrome None General disorders CTCAEv4 View
Rash maculo-papular None Skin and subcutaneous tissue disorders CTCAEv4 View
Pruritus None Skin and subcutaneous tissue disorders CTCAEv4 View
Diarrhea None Gastrointestinal disorders CTCAEv4 View
Hypertension None Vascular disorders CTCAEv4 View
Alopecia None Skin and subcutaneous tissue disorders CTCAEv4 View
Hypercalcemia None Metabolism and nutrition disorders CTCAEv4 View
Fatigue None General disorders CTCAEv4 View
Arthralgia None Musculoskeletal and connective tissue disorders CTCAEv4 View
Dry skin None Skin and subcutaneous tissue disorders CTCAEv4 View
Nausea None Gastrointestinal disorders CTCAEv4 View
Dysgeusia None Nervous system disorders CTCAEv4 View
Weight loss None Investigations CTCAEv4 View
Oral pain None Gastrointestinal disorders CTCAEv4 View
Flatulence None Gastrointestinal disorders CTCAEv4 View
Flushing None Vascular disorders CTCAEv4 View